1. Corporate Officers - N
2. Niven Ralph

Insider Trading History of Niven Ralph

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Niven Ralph since 2005. This trader's CIK number is 1168060. At the time of last reporting, Niven Ralph was the CHIEF SCIENTIFIC OFFICER of Aerovate Therapeutics, Inc.. (stock ticker symbol AVTE). Also see all insider trading activities at Aerovate Therapeutics, Inc..

Note that in the past NIVEN RALPH also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Windtree Therapeutics Inc /de/ (DSCO) by Niven Ralph

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2005	DSCO	0	$0	5,783	$38,474	0	$0

Yearly summary of insider trading at Aerovate Therapeutics, Inc. (AVTE) by Niven Ralph

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	AVTE	0	$0	9,200	$168,212	9,200	$17,848
2023	AVTE	0	$0	34,150	$616,181	34,150	$66,251
2022	AVTE	0	$0	2,250	$35,921	2,250	$4,365

Insider trading activities at 2 companies by Niven Ralph:

1. Windtree Therapeutics Inc /de/ (DSCO)

2. Aerovate Therapeutics, Inc. (AVTE)

Table 1. Insider trading of Windtree Therapeutics Inc /de/ (DSCO) by Niven Ralph

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2005-05-23	DSCO	Sale	5,783	6.65	38,474

Table 2. Insider trading of Aerovate Therapeutics, Inc. (AVTE) by Niven Ralph

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-02-05	AVTE	Option Ex	4,600	1.94	8,924
2024-02-05	AVTE	Sale	4,600	17.45	80,251
2024-01-05	AVTE	Option Ex	4,600	1.94	8,924
2024-01-05	AVTE	Sale	4,600	19.12	87,961
2023-12-05	AVTE	Option Ex	4,600	1.94	8,924
2023-12-05	AVTE	Sale	4,600	16.30	74,993
2023-11-22	AVTE	Sale	13,800	15.00	207,000
2023-11-22	AVTE	Option Ex	13,800	1.94	26,772
2023-07-05	AVTE	Option Ex	2,250	1.94	4,365
2023-07-05	AVTE	Sale	2,250	17.55	39,489
2023-06-05	AVTE	Option Ex	2,250	1.94	4,365
2023-06-05	AVTE	Sale	2,250	16.26	36,576
2023-05-05	AVTE	Option Ex	2,250	1.94	4,365
2023-05-05	AVTE	Sale	2,250	21.21	47,731
2023-04-05	AVTE	Option Ex	2,250	1.94	4,365
2023-04-05	AVTE	Sale	2,250	18.51	41,645
2023-03-06	AVTE	Option Ex	2,250	1.94	4,365
2023-03-06	AVTE	Sale	2,250	24.32	54,731
2023-02-06	AVTE	Sale	2,250	24.27	54,612
2023-02-06	AVTE	Option Ex	2,250	1.94	4,365
2023-01-05	AVTE	Option Ex	2,250	1.94	4,365
2023-01-05	AVTE	Sale	2,250	26.40	59,404
2022-10-05	AVTE	Option Ex	2,250	1.94	4,365
2022-10-05	AVTE	Sale	2,250	15.96	35,921

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Niven Ralph (CHIEF SCIENTIFIC OFFICER of Aerovate Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month